Evidence map›Paper›PMID 29983388›Full record

ArticleStem cell reports2018

FGF2 Induces Migration of Human Bone Marrow Stromal Cells by Increasing Core Fucosylations on N-Glycans of Integrins.

Baarkullah Awan, David Turkov, Cameron Schumacher, Antonio Jacobo, Amber McEnerney, Ashley Ramsey, Gege Xu, Dayoung Park, Stefanos Kalomoiris, Wei Yao and 4 more

Open access · goldAbstract read
In one paragraph

Article in Stem cell reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. FGF2 as a Potential Tumor Suppressor in Lung Adenocarcinoma.Diagnostics (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Cancers · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Anti-fibrotic effects of pharmacologic FGF-2: a review of recent literature.Journal of molecular medicine (Berlin, Germany) · 2022
    Review
  13. Article
  14. Article
  15. Mesenchymal Stem Cells for Neurological Disorders.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2021
    Review
  16. Article
  17. Article
  18. Metastasis of cholangiocarcinoma is promoted by extended high-mannose glycans.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Baarkullah AwanInstitute for Regenerative Cures, University of California, Davis, Sacramento, CA, USA.
David TurkovInstitute for Regenerative Cures, University of California, Davis, Sacramento, CA, USA.
Cameron SchumacherInstitute for Regenerative Cures, University of California, Davis, Sacramento, CA, USA.
Antonio JacoboInstitute for Regenerative Cures, University of California, Davis, Sacramento, CA, USA.
Amber McEnerneyInstitute for Regenerative Cures, University of California, Davis, Sacramento, CA, USA.
Ashley RamseyInstitute for Regenerative Cures, University of California, Davis, Sacramento, CA, USA.
Gege XuDepartment of Chemistry, University of California, Davis, Davis, CA, USA.
Dayoung ParkDepartment of Chemistry, University of California, Davis, Davis, CA, USA.
Stefanos KalomoirisInstitute for Regenerative Cures, University of California, Davis, Sacramento, CA, USA.
Wei YaoCenter for Musculoskeletal Health, Department of Internal Medicine, University of California, Davis, Davis, CA, USA.
Li-En JaoDepartment of Cell Biology and Human Anatomy, University of California, Davis, Davis, CA, USA.
Miguel L AllendeDepartment of Cell Biology and Human Anatomy, University of California, Davis, Davis, CA, USA; Center for Genome Regulation, Facultad de Ciencias, Universidad de Chile, Santiago, Chile.
Carlito B LebrillaDepartment of Chemistry, University of California, Davis, Davis, CA, USA.
Fernando A FierroInstitute for Regenerative Cures, University of California, Davis, Sacramento, CA, USA; Department of Cell Biology and Human Anatomy, University of California, Davis, Davis, CA, USA. Electronic address: ffierro@ucdavis.edu.
California Institute for Regenerative Medicine · USUniversity of California, Davis · USUniversity of Chile · CL

Funding

Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI Laura Marcu · 2002 to 2026
$84.9M
6 · The paper itself

Abstract

Since hundreds of clinical trials are investigating the use of multipotent stromal cells (MSCs) for therapeutic purposes, effective delivery of the cells to target tissues is critical. We have found an unexplored mechanism, by which basic fibroblast growth factor (FGF2) induces expression of fucosyltransferase 8 (FUT8) to increase core fucosylations of N-linked glycans of membrane-associated proteins, including several integrin subunits. Gain- and loss-of-function experiments show that FUT8 is both necessary and sufficient to induce migration of MSCs. Silencing FUT8 also affects migration of MSCs in zebrafish embryos and a murine bone fracture model. Finally, we use in silico modeling to show that core fucosylations restrict the degrees of freedom of glycans on the integrin's surface, hence stabilizing glycans on a specific position. Altogether, we show a mechanism whereby FGF2 promotes migration of MSCs by modifying N-glycans. This work may help improve delivery of MSCs in therapeutic settings.

Indexed as

AnimalsCell MovementFibroblast Growth Factor 2Gene Expression ProfilingGene Expression RegulationGlycosylationHumansIntegrinsMesenchymal Stem CellsMiceModels, MolecularMolecular ConformationPolysaccharidesStructure-Activity RelationshipFibroblast Growth Factor 2IntegrinsPolysaccharidescore fucosylationFUT8mesenchymal stem cellsmigrationMSCmultipotent stromal cells

Identifiers

PMID29983388
PMCPMC6093088
OpenAlexW2866683234

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.